Research map: Targeting chronic mucus hypersecretion in respiratory diseases – focus on OPEP devices
Back to the article
Papers in this map
- Chronic Bronchitis and Chronic Obstructive Pulmonary Disease · Victor Kim · 2012 · 520 citations · Cited by this paper
- Immunosuppressive medication patterns in rheumatoid arthritis–associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic health record study · 2026 · Related
- Airway Mucin Concentration as a Marker of Chronic Bronchitis · Mehmet Kesımer · 2017 · 391 citations · Cited by this paper
- Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease · 2026 · Related
- Mucoactive drugs · Rossella Balsamo · 2010 · 159 citations · Cited by this paper
- Adults with congenital lung malformations: A descriptive analysis of an underexplored population · 2026 · Related
- European Respiratory Society clinical practice guideline for the management of adult bronchiectasis · James Duncan Chalmers · 2025 · 131 citations · Cited by this paper
- Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes · 2026 · Related
- Personalising airway clearance in chronic lung disease · Maggie Patricia McIlwaine · 2017 · 122 citations · Cited by this paper
- Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma · 2026 · Related
- Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition) · Yongchun Shen · 2018 · 120 citations · Cited by this paper
- Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience · 2026 · Related
- Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry · Raja Dhar · 2022 · 110 citations · Cited by this paper
- Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients · 2026 · Related
- Bronchiectasis management in adults: state of the art and future directions · Hayoung Choi · 2024 · 108 citations · Cited by this paper
- Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management · 2026 · Related
- Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases · Michela Abrami · 2024 · 103 citations · Cited by this paper
- Oxidative Stress–Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications · 2026 · Related
- European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis · Beatriz Herrero‐Cortina · 2023 · 100 citations · Cited by this paper
- Smoking cessation and depression risk in newly diagnosed COPD patients: A nationwide cohort study · 2026 · Related
- Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine · Paola Rogliani · 2019 · 85 citations · Cited by this paper
- Rheological analysis of sputum from patients with chronic bronchial diseases · J. Patarin · 2020 · 74 citations · Cited by this paper
- Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment · Binay Kumar Shah · 2023 · 66 citations · Cited by this paper
- Silent Airway Mucus Plugs in COPD and Clinical Implications · Sofia K. Mettler · 2023 · 65 citations · Cited by this paper
- Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial · Qian Qi · 2019 · 59 citations · Cited by this paper
- Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease · Sarah Svenningsen · 2015 · 57 citations · Cited by this paper
- Effect of High/Low Dose N-Acetylcysteine on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis · Yanfei Shen · 2013 · 56 citations · Cited by this paper
- Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases · Daniela Mokrá · 2023 · 53 citations · Cited by this paper
- Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations · Carlos Martínez‐Rivera · 2018 · 50 citations · Cited by this paper
- Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review · Luís Máiz · 2019 · 41 citations · Cited by this paper
- Bronchiectasis · Miguel Trigueiro Rocha Barbosa · 2023 · 40 citations · Cited by this paper
- Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation · Peter M.A. Calverley · 2019 · 35 citations · Cited by this paper
- The efficacy of N -acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis · Chienhsiu Huang · 2023 · 33 citations · Cited by this paper
- Performance Characteristics of Positive Expiratory Pressure Devices · Angela M Demchuk · 2020 · 28 citations · Cited by this paper
- Evaluation of Functional Characteristics of 4 Oscillatory Positive Pressure Devices in a Simulated Cystic Fibrosis Model · Hillary Van Fleet · 2017 · 26 citations · Cited by this paper
- Autogenic drainage for airway clearance in cystic fibrosis · Paul Burnham · 2021 · 26 citations · Cited by this paper
- High-Dose N-Acetylcysteine in the Prevention of COPD Exacerbations: Rationale and Design of the PANTHEON Study · Jin-Ping Zheng · 2012 · 24 citations · Cited by this paper
- Comparison of 6 Oscillatory Positive Expiratory Pressure Devices During Active Expiratory Flow · William Poncin · 2019 · 24 citations · Cited by this paper
- Bronchiectasis in Asia: a review of current status and challenges · Hayoung Choi · 2024 · 24 citations · Cited by this paper
Source: OpenAlex (CC0)